187 related articles for article (PubMed ID: 11812785)
1. The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2.
Wang Z; Tseng CP; Pong RC; Chen H; McConnell JD; Navone N; Hsieh JT
J Biol Chem; 2002 Apr; 277(15):12622-31. PubMed ID: 11812785
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2.
Zhou J; Hsieh JT
J Biol Chem; 2001 Jul; 276(30):27793-8. PubMed ID: 11371563
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer.
Zhou J; Scholes J; Hsieh JT
J Biol Chem; 2003 Feb; 278(9):6936-41. PubMed ID: 12473651
[TBL] [Abstract][Full Text] [Related]
4. The role of DOC-2/DAB2 protein phosphorylation in the inhibition of AP-1 activity. An underlying mechanism of its tumor-suppressive function in prostate cancer.
Tseng CP; Ely BD; Pong RC; Wang Z; Zhou J; Hsieh JT
J Biol Chem; 1999 Nov; 274(45):31981-6. PubMed ID: 10542228
[TBL] [Abstract][Full Text] [Related]
5. The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.
Zhoul J; Hernandez G; Tu SW; Huang CL; Tseng CP; Hsieh JT
Cancer Res; 2005 Nov; 65(21):9906-13. PubMed ID: 16267015
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DOC-2/DAB2 delivered by a unique vehicle.
Zhou J; Fan J; Hsieh JT
Cancer Res; 2006 Sep; 66(18):8954-8. PubMed ID: 16982733
[TBL] [Abstract][Full Text] [Related]
7. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
Zhou J; Hernandez G; Tu SW; Scholes J; Chen H; Tseng CP; Hsieh JT
Cancer Res; 2005 Jul; 65(14):6089-96. PubMed ID: 16024609
[TBL] [Abstract][Full Text] [Related]
8. Regulation of rat DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells.
Tseng CP; Ely BD; Li Y; Pong RC; Hsieh JT
Endocrinology; 1998 Aug; 139(8):3542-53. PubMed ID: 9681506
[TBL] [Abstract][Full Text] [Related]
9. DOC-2/DAB2 is the binding partner of myosin VI.
Inoue A; Sato O; Homma K; Ikebe M
Biochem Biophys Res Commun; 2002 Mar; 292(2):300-7. PubMed ID: 11906161
[TBL] [Abstract][Full Text] [Related]
10. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
Xu XX; Yi T; Tang B; Lambeth JD
Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization.
Chen H; Pong RC; Wang Z; Hsieh JT
Genomics; 2002 Apr; 79(4):573-81. PubMed ID: 11944990
[TBL] [Abstract][Full Text] [Related]
12. Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation.
He J; Smith ER; Xu XX
J Biol Chem; 2001 Jul; 276(29):26814-8. PubMed ID: 11359772
[TBL] [Abstract][Full Text] [Related]
13. The gene encoding the mitogen-responsive phosphoprotein Dab2 is differentially regulated by GATA-6 and GATA-4 in the visceral endoderm.
Morrisey EE; Musco S; Chen MY; Lu MM; Leiden JM; Parmacek MS
J Biol Chem; 2000 Jun; 275(26):19949-54. PubMed ID: 10779506
[TBL] [Abstract][Full Text] [Related]
14. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
[TBL] [Abstract][Full Text] [Related]
15. Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate.
Chen H; Karam JA; Schultz R; Zhang Z; Duncan C; Hsieh JT
DNA Cell Biol; 2006 Apr; 25(4):232-45. PubMed ID: 16629596
[TBL] [Abstract][Full Text] [Related]
16. DAB2IP in cancer.
Liu L; Xu C; Hsieh JT; Gong J; Xie D
Oncotarget; 2016 Jan; 7(4):3766-76. PubMed ID: 26658103
[TBL] [Abstract][Full Text] [Related]
17. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer.
Mok SC; Chan WY; Wong KK; Cheung KK; Lau CC; Ng SW; Baldini A; Colitti CV; Rock CO; Berkowitz RS
Oncogene; 1998 May; 16(18):2381-7. PubMed ID: 9620555
[TBL] [Abstract][Full Text] [Related]
18. Disabled-2: A modular scaffold protein with multifaceted functions in signaling.
Finkielstein CV; Capelluto DG
Bioessays; 2016 Jul; 38 Suppl 1():S45-55. PubMed ID: 27417122
[TBL] [Abstract][Full Text] [Related]
19. GC-GAP, a Rho family GTPase-activating protein that interacts with signaling adapters Gab1 and Gab2.
Zhao C; Ma H; Bossy-Wetzel E; Lipton SA; Zhang Z; Feng GS
J Biol Chem; 2003 Sep; 278(36):34641-53. PubMed ID: 12819203
[TBL] [Abstract][Full Text] [Related]
20. The role of disabled-2 (Dab2) in diseases.
Ogbu SC; Musich PR; Zhang J; Yao ZQ; Howe PH; Jiang Y
Gene; 2021 Feb; 769():145202. PubMed ID: 33059028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
